Increase In Pay For Part B Hospital Outpatient Drugs Needed, Groups Tell CMS
Executive Summary
CMS' proposal to drop Medicare Part B drug reimbursement to average sales price plus 4 percent in the hospital outpatient setting is being met with calls for the agency to return to ASP plus 6 percent, the same rate physicians are reimbursed for drugs administered in their offices
You may also be interested in...
CMS Drops Rates For Hospital Outpatient Drugs To ASP+4%
Stakeholders fail to convince agency to return rate to ASP+6% to match payment in physician setting.
Stakeholders Oppose Proposal To Cut IVIG Preadministration Fee In Medicare
Industry groups are asking CMS to back off on a proposal to cut the $37 preadministration fee for intravenous immune globulin therapies administered in the hospital outpatient setting
Stakeholders Oppose Proposal To Cut IVIG Preadministration Fee In Medicare
Industry groups are asking CMS to back off on a proposal to cut the $37 preadministration fee for intravenous immune globulin therapies administered in the hospital outpatient setting